Zevin Asset Management’s Core Laboratories CLB Stock Holding History

Zevin Asset Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-1,900	Closed	-$217K	–	136
2015 Q2	$217K	Sell	1,900 -175	-8%	-$21.2K	0.06%	130
2015 Q1	$217K	Hold	2,075	–	–	0.06%	129
2014 Q4	$250K	Hold	2,075	–	–	0.07%	125
2014 Q3	$304K	Hold	2,075	–	–	0.09%	104
2014 Q2	$347K	Hold	2,075	–	–	0.1%	101
2014 Q1	$412K	Hold	2,075	–	–	0.13%	83
2013 Q4	$396K	Hold	2,075	–	–	0.11%	86
2013 Q3	$351K	Hold	2,075	–	–	0.11%	87
2013 Q2	$315K	Buy	+2,075	New	+$294K	0.11%	87

Other funds holding CLB

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Wedgewood Partners St Louis, Missouri $484M AUM 16.04% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Zevin Asset Management's CLB Position: Q3 2015 in Review

Zevin Asset Management sold out of Core Laboratories (CLB) in Q3 2015, closing a stake of 1,900 shares — an estimated $217K sold.

Zevin Asset Management first reported a position in CLB in Q2 2013 and held it in 9 quarters. The position peaked at $412K in Q1 2014. 352 funds tracked by Wall St. Rank hold CLB as of Q3 2015.

Zevin Asset Management reported no remaining Core Laboratories position as of Q3 2015 after selling out during the quarter.
Zevin Asset Management sold 1,900 Core Laboratories shares in Q3 2015, an estimated $217K.
Zevin Asset Management first reported a position in Core Laboratories in Q2 2013 and held it in 9 quarters.
Zevin Asset Management's Core Laboratories position peaked at $412K in Q1 2014.
352 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2015.

Based on Zevin Asset Management's 13F filing for Q3 2015, filed 12 Nov 2015.